{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-000502","form_type":"8-K","ticker":"KALA","cik":"0001479419","company_name":"KALA BIO, Inc.","filed_at":"2026-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.169474+00:00","generated_at":"2026-05-16T08:22:49.007697+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"confidence":"high","headline":"KALA BIO receives Nasdaq bid price deficiency notice; 180-day compliance period until July 20, 2026","bullets":["Letter dated Jan 20, 2026; closing bid price below $1.00 for 30 consecutive business days (Dec 3, 2025–Jan 16, 2026).","Must maintain closing bid price ≥$1.00 for at least ten consecutive business days during the compliance period to regain compliance.","If not cured by July 20, 2026, may be eligible for an additional 180-day period if other Nasdaq listing standards are met.","No immediate impact on stock listing; shares continue trading on Nasdaq subject to other requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-000502","json":"https://secwatch.observer/filing/0001829126-26-000502.json","markdown":"https://secwatch.observer/filing/0001829126-26-000502.md","text":"https://secwatch.observer/filing/0001829126-26-000502.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000502/0001829126-26-000502-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000502/kalabio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T08:22:49.007697+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}